BARCLAY A PHILLIPS
CIK 1265801 · SVP & Chief Financial Officer · last filed 2025-06-09
BARCLAY A PHILLIPS is a SVP & Chief Financial Officer who has filed 43 SEC Form 4 insider transactions across 5 companies since 2007. The most recent filing, for IMUX, was dated Jun 9, 2025. Across all open-market trades the lifetime net is −$7.7M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $343.4K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$343.4K
5
43
-$7.70M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| IMUX | Director | — | $13.86 | — | $0 | 8 | 2025-06-09 |
| G1 Therapeutics, Inc. (GTHX) Delisted | SVP & Chief Financial Officer | 5,000 | $7.15 | $35.8K | -$199.6K | 3 | 2019-01-02 |
| NVAX | SVP, Chief Financial Officer | 38,669 | $8.88 | $343.4K | -$167.1K | 19 | 2017-08-01 |
| MICROMET, INC. (MITI) Delisted | SVP, CFO | 0 | — | — | -$213.6K | 9 | 2012-03-06 |
| Acorda Therapeutics, Inc. (ACOR) Delisted | Director | 333,419 | $0.66 | $220.4K | -$7.12M | 3 | 2008-06-16 |
Recent Filings
43 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-06-09 | IMUX | Grant (A) | — | $0 | EDGAR |
| 2024-06-12 | IMUX | Grant (A) | — | $0 | EDGAR |
| 2024-03-06 | IMUX | Mixed | — | $0 | EDGAR |
| 2023-06-29 | IMUX | Grant (A) | — | $0 | EDGAR |
| 2022-06-17 | IMUX | Grant (A) | — | $0 | EDGAR |
| 2021-06-14 | IMUX | Grant (A) | — | $0 | EDGAR |
| 2020-07-06 | IMUX | Grant (A) | — | $0 | EDGAR |
| 2019-11-19 | IMUX | Grant (A) | — | $0 | EDGAR |
| 2019-01-02 | G1 Therapeutics, Inc. (GTHX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2018-11-16 | G1 Therapeutics, Inc. (GTHX) Delisted | Mixed | — | -$102.3K | EDGAR |